NeuPath Health Inc.
NPTH.V
TSX
| Weiss Ratings | NPTH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | NPTH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | NPTH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.57 | |||
| Price History | NPTH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -2.50% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | -4.88% | |||
| 90-Day Total Return | 18.18% | |||
| Year to Date Total Return | -11.36% | |||
| 1-Year Total Return | 5.41% | |||
| 2-Year Total Return | 21.88% | |||
| 3-Year Total Return | -64.55% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -22.45% | |||
| 52-Week Low % Change | 35.71% | |||
| Price | NPTH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.25 | |||
| 52-Week Low Price | $0.14 | |||
| 52-Week Low Price (Date) | Apr 15, 2024 | |||
| 52-Week High Price (Date) | Jan 06, 2025 | |||
| Valuation | NPTH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 7.44M | |||
| Enterprise Value | 13.32M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.02 | |||
| Earnings Per Share Growth | -32.62% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.21 | |||
| Price/Book (Q) | 0.67 | |||
| Enterprise Value/Revenue (TTM) | 0.26 | |||
| Price | $0.20 | |||
| Enterprise Value/EBITDA (TTM) | 5.77 | |||
| Enterprise Value/EBIT | 15.95 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | NPTH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 56.60M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | NPTH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 905 858 1368 | |||
| Address | 6400 Millcreek Drive Mississauga, ON L5N 3E7 | |||
| Website | www.neupath.com | |||
| Country | Canada | |||
| Year Founded | -- | |||
| Profitability | NPTH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 1.60% | |||
| Profit Margin | -1.21% | |||
| Management Effectiveness | NPTH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 1.69% | |||
| Return on Equity | -- | |||
| Income Statement | NPTH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 51.99M | |||
| Total Revenue (TTM) | 51.99M | |||
| Revenue Per Share | $0.92 | |||
| Gross Profit (TTM) | 9.90M | |||
| EBITDA (TTM) | 2.31M | |||
| EBIT (TTM) | 835.30K | |||
| Net Income (TTM) | -629.30K | |||
| Net Income Avl. to Common (TTM) | -629.30K | |||
| Total Revenue Growth (Q YOY) | 7.31% | |||
| Earnings Growth (Q YOY) | -189.22% | |||
| EPS Diluted (TTM) | -0.02 | |||
| EPS Diluted Growth (Q YOY) | -246.00% | |||
| Balance Sheet | NPTH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 2.33M | |||
| Cash Per Share (Q) | $0.04 | |||
| Total Current Assets (Q) | 8.28M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 16.00M | |||
| Current Ratio (Q) | 0.959 | |||
| Book Value Per Share (Q) | $0.28 | |||
| Total Assets (Q) | 30.90M | |||
| Total Current Liabilities (Q) | 8.63M | |||
| Total Debt (Q) | 8.63M | |||
| Total Liabilities (Q) | 14.90M | |||
| Total Common Equity (Q) | 16.03M | |||
| Cash Flow | NPTH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -715.20K | |||
| Cash from Financing (TTM) | -1.39M | |||
| Net Change in Cash (TTM) | 65.90K | |||
| Levered Free Cash Flow (TTM) | 1.62M | |||
| Cash from Operations (TTM) | 2.17M | |||
